Clinical trial
Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus…
NCT00119678 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00119678 |
|---|---|
| Title | Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone |
| Official title | A Phase IIB, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept vs Placebo on a Background of Oral Glucocorticosteroids in the Treatment of Subjects With Systemic Lupus Erythematosus and the Prevention of Subsequent Lupus Flares |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Systemic Lupus Erythematosus |
| Intervention type | Drug |
| Interventions | Abatacept, Placebo, Prednisone |
| Enrollment | 183 |
| Start date | Sep 1, 2005 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Jul 14, 2005 |
| Last update posted | Sep 22, 2014 |
| Countries | Australia, Austria, Belgium, Brazil, Canada, France, Germany, Italy, Mexico, Puerto Rico, South Africa, South Korea and 3 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: